AlphaFold predicted structure
NDST1 · P52848

Mean pLDDT
90.0/ 100
Very high
882 residues
Confidence breakdown
- Very high(≥ 90)82%
- Confident(70–90)8%
- Low(50–70)3%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
N-deacetylase and N-sulfotransferase 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalautosomal recessive non-syndromic intellectual disability
Abnormality of the skeletal system
Intellectual disability
osteoarthritis, knee
osteoarthritis, hip
Global developmental delay
Graves disease
hereditary disease
cleft lip/palate
Congenital pulmonary alveolar proteinosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
Essential bifunctional enzyme that catalyzes both the N-deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate (PubMed:35137078, PubMed:9230113, PubMed:9744796). Modifies the GlcNAc-GlcA disaccharide repeating sugar backbone to make N-sulfated heparosan, a prerequisite substrate for later modifications in heparin biosynthesis (PubMed:9230113). Plays a role in determining the extent and pattern of sulfation of heparan sulfate. Participates in biosynthesis of heparan sulfate that can ultimately serve as L-selectin ligands, thereby playing a role in inflammatory response (By similarity). Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413)
NDST1 · P52848

Mean pLDDT
90.0/ 100
Very high
882 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0